Virbac SA
V16
Company Profile
Business description
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.
Contact
13e rue LID - BP 27
Carros06511
FRAT: +33 492087100
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
5,620
Stocks News & Analysis
stocks
Nvidia Earnings: No signs of a slowdown in demand for AI chips
A selloff in Nvidia stock on the earnings news looks like a buying opportunity to us.
stocks
ASX results reaction: WiseTech, Woolies, Sigma and more
A round up of notable stories and reactions as ASX reporting season rolls on.
stocks
WiseTech result disappoints, but the future looks bright
Markets appear underwhelmed by recent sales growth, however, our kingmaker thesis is intact.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,243.00 | 9.00 | 0.10% |
CAC 40 | 7,703.90 | 58.70 | -0.76% |
DAX 40 | 23,902.21 | 137.71 | -0.57% |
Dow JONES (US) | 45,544.88 | 92.02 | -0.20% |
FTSE 100 | 9,187.34 | 29.48 | -0.32% |
HKSE | 25,077.62 | 78.80 | 0.32% |
NASDAQ | 21,455.55 | 249.61 | -1.15% |
Nikkei 225 | 42,718.47 | 110.32 | -0.26% |
NZX 50 Index | 12,930.73 | 27.65 | 0.21% |
S&P 500 | 6,460.26 | 41.60 | -0.64% |
S&P/ASX 200 | 8,973.10 | 4.10 | 0.05% |
SSE Composite Index | 3,857.93 | 14.33 | 0.37% |